New eye drug shows promise for Diabetes-Related vision loss
NCT ID NCT05301751
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 37 times
Summary
This study tested an experimental drug called AG-73305 in 25 adults with diabetic macular edema, a condition that causes vision loss due to diabetes. Participants received a single injection into the eye, and researchers monitored safety and vision changes over 6 months. The goal was to find the best dose for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Center of Macula and Retina Disease
Winter Haven, Florida, 33880, United States
-
Retina Research Institute of Texas
Abilene, Texas, 79606, United States
-
Retina Vitreous Associates of Florida
St. Petersburg, Florida, 33711, United States
-
Strategic Clinical Research Group, LLC
Willow Park, Texas, 76087, United States
-
Texas Retina Associates
Fort Worth, Texas, 76104, United States
-
Valley Retina Institute
McAllen, Texas, 78503, United States
Conditions
Explore the condition pages connected to this study.